News

Vienna BioCenter-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the...

Read more

PhD students Henry Thomas and Claudia Pachinger have been awarded the uni:docs Fellowships. Congratulations also to Katharina Siess and Michael...

Read more

On Thursday the 5th September 2019, the Vienna BioCenter Postdoc Symposium on Publishing Models took place. The reason for organizing it was the...

Read more

The immune system relies on B cells and their ability to make antibodies against an extremely broad range of pathogens. This broad responsiveness...

Read more

The Medical University of Vienna has nominated Anete Romanauska as Researcher of the Month. Born in Latvia, she studied Biology in Riga and later in...

Read more

Valneva announced that it has completed patient recruitment of the Phase 2 studies for its Lyme disease vaccine candidate, VLA15.

Read more

Read more

Protein Kinase D (PKD) is an enzyme at the heart of many cellular functions. By modifying other proteins, it controls the trafficking of essential...

Read more

Eucodis developed and patented a catalase as a novel neutralizer in environmental monitoring media and offers either a collaboration or OEM supply of...

Read more

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

Read more

Emily Bayer of Columbia University, Mohamed El-Brolosy of the Max Planck Institute for Heart and Lung Research, and Justin Silpe of Princeton...

Read more

Visit the Vienna BioCenter on Friday, 11 October 2019 and learn about research opportunities at our campus.

Read more

Alejandro Burga, group leader at IMBA - Institute of Molecular Biotechnology, has been awarded the Starting Grant of the European Research Council,...

Read more